Amadeusz Juskowiak

Beecham unit launches arthritis drug

Beecham Group Plc BHAML said its subsidiary Beecham Pharmaceuticals launched a new onceaday prescription only medicine for the reduction of pain and inflammation caused by rheumatoid and osteoarthritis The launch took place simultaneously in the UK And West Germany

The drug which has the approved name Nabumetone will be introduced to doctors in the UK Under the brand name of Relifex and will be known as Arthaxan in West Germany